CN101491585A - 一种具有清咽功能的中药组合物及其制备方法 - Google Patents
一种具有清咽功能的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101491585A CN101491585A CNA2008100567064A CN200810056706A CN101491585A CN 101491585 A CN101491585 A CN 101491585A CN A2008100567064 A CNA2008100567064 A CN A2008100567064A CN 200810056706 A CN200810056706 A CN 200810056706A CN 101491585 A CN101491585 A CN 101491585A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- fructus
- preparation
- medicine composition
- herba pileae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000002131 composite material Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 27
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 241000628997 Flos Species 0.000 claims description 20
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 238000011010 flushing procedure Methods 0.000 claims description 5
- 241000245240 Lonicera Species 0.000 claims description 2
- 235000009815 Momordica Nutrition 0.000 claims description 2
- 241000218984 Momordica Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 1
- 235000013402 health food Nutrition 0.000 claims 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000012254 Canarium album Species 0.000 abstract 1
- 235000009103 Canarium album Nutrition 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 235000010842 Sarcandra glabra Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 11
- 230000036407 pain Effects 0.000 description 10
- 201000007100 Pharyngitis Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 241000699670 Mus sp. Species 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000003800 pharynx Anatomy 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 210000003026 hypopharynx Anatomy 0.000 description 5
- 241000712461 unidentified influenza virus Species 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 241000193998 Streptococcus pneumoniae Species 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 208000016150 acute pharyngitis Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010018286 Gingival pain Diseases 0.000 description 2
- 206010018291 Gingival swelling Diseases 0.000 description 2
- 241000701096 Human adenovirus 7 Species 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001500350 Influenzavirus B Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000001705 Mouth breathing Diseases 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- -1 ketone compounds Chemical class 0.000 description 1
- 201000005264 laryngeal carcinoma Diseases 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100567064A CN101491585B (zh) | 2008-01-23 | 2008-01-23 | 一种具有清咽功能的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100567064A CN101491585B (zh) | 2008-01-23 | 2008-01-23 | 一种具有清咽功能的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101491585A true CN101491585A (zh) | 2009-07-29 |
CN101491585B CN101491585B (zh) | 2012-05-30 |
Family
ID=40922486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100567064A Expired - Fee Related CN101491585B (zh) | 2008-01-23 | 2008-01-23 | 一种具有清咽功能的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101491585B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102379915A (zh) * | 2011-10-25 | 2012-03-21 | 福建省医学科学研究院 | 橄榄泡腾片及其制备方法 |
CN103070989A (zh) * | 2012-09-24 | 2013-05-01 | 吴江市精工铝字制造厂 | 一种含片及其制备方法 |
CN103211067A (zh) * | 2013-05-10 | 2013-07-24 | 北京绿源求证科技发展有限责任公司 | 一种清咽食品养生茶冲剂 |
CN103431126A (zh) * | 2013-09-18 | 2013-12-11 | 广西龙胜巾帼生态农业开发有限公司 | 具有保健功能的罗汉果金银花固体茶 |
CN103621718A (zh) * | 2012-08-29 | 2014-03-12 | 宁国红楼梦旅游产品开发有限公司 | 一种地肤子茶及其制作方法 |
CN103652099A (zh) * | 2012-09-01 | 2014-03-26 | 宁国红楼梦旅游产品开发有限公司 | 一种柏子仁茶及其制作方法 |
CN104286309A (zh) * | 2014-10-23 | 2015-01-21 | 广西神龙王农牧食品集团有限公司 | 一种金银花饮料的制作方法 |
CN105267445A (zh) * | 2015-11-20 | 2016-01-27 | 广西医科大学制药厂 | 金花茶咽喉含片及其制备方法和应用 |
CN105796894A (zh) * | 2016-03-14 | 2016-07-27 | 南方医科大学 | 一种解热中药组合物及制剂 |
CN107568554A (zh) * | 2017-09-30 | 2018-01-12 | 朱昱光 | 一种固体饮料 |
CN109965337A (zh) * | 2018-11-20 | 2019-07-05 | 贵州云上苗家康养有限公司 | 一种苗族戒烟食品及其制备方法 |
-
2008
- 2008-01-23 CN CN2008100567064A patent/CN101491585B/zh not_active Expired - Fee Related
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102379915A (zh) * | 2011-10-25 | 2012-03-21 | 福建省医学科学研究院 | 橄榄泡腾片及其制备方法 |
CN103621718A (zh) * | 2012-08-29 | 2014-03-12 | 宁国红楼梦旅游产品开发有限公司 | 一种地肤子茶及其制作方法 |
CN103652099A (zh) * | 2012-09-01 | 2014-03-26 | 宁国红楼梦旅游产品开发有限公司 | 一种柏子仁茶及其制作方法 |
CN103070989A (zh) * | 2012-09-24 | 2013-05-01 | 吴江市精工铝字制造厂 | 一种含片及其制备方法 |
CN103211067A (zh) * | 2013-05-10 | 2013-07-24 | 北京绿源求证科技发展有限责任公司 | 一种清咽食品养生茶冲剂 |
CN103431126A (zh) * | 2013-09-18 | 2013-12-11 | 广西龙胜巾帼生态农业开发有限公司 | 具有保健功能的罗汉果金银花固体茶 |
CN104286309A (zh) * | 2014-10-23 | 2015-01-21 | 广西神龙王农牧食品集团有限公司 | 一种金银花饮料的制作方法 |
CN105267445A (zh) * | 2015-11-20 | 2016-01-27 | 广西医科大学制药厂 | 金花茶咽喉含片及其制备方法和应用 |
CN105796894A (zh) * | 2016-03-14 | 2016-07-27 | 南方医科大学 | 一种解热中药组合物及制剂 |
CN105796894B (zh) * | 2016-03-14 | 2019-10-01 | 南方医科大学 | 一种解热中药组合物及制剂 |
CN107568554A (zh) * | 2017-09-30 | 2018-01-12 | 朱昱光 | 一种固体饮料 |
CN109965337A (zh) * | 2018-11-20 | 2019-07-05 | 贵州云上苗家康养有限公司 | 一种苗族戒烟食品及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101491585B (zh) | 2012-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101491585B (zh) | 一种具有清咽功能的中药组合物及其制备方法 | |
CN112022957A (zh) | 一种中药润肺排毒清肺茶 | |
CN104295051B (zh) | 一种活性生态环保地板 | |
CN104171226A (zh) | 一种清咽润喉糖果的配方 | |
CN104840734B (zh) | 清咽保健中药组合物及其制备方法和应用 | |
CN103816281B (zh) | 一种预防和治疗风热感冒的中药组合物 | |
CN102357176B (zh) | 抗感冒中药组合物 | |
CN104304629A (zh) | 一种中药香型口香糖 | |
CN108938947A (zh) | 一种板蓝根茶饮剂及其制备方法 | |
CN103610061B (zh) | 一种吸烟者使用保健品 | |
CN102526236A (zh) | 一种治疗流行性感冒的药物及其制备方法 | |
CN101569714B (zh) | 治疗慢性咽炎的中药复方及其制备方法 | |
CN105770648A (zh) | 治疗感冒的内服中药制剂 | |
CN105106565A (zh) | 一种清热利咽解毒的中药组合物 | |
CN104524176A (zh) | 一种治疗咽喉肿痛的中药配方 | |
CN102205048A (zh) | 一种具有清咽功能的药物组合物 | |
CN104524256A (zh) | 一种用于治疗病毒性肺炎的中药 | |
CN115990228B (zh) | 一种缓解咽炎和止咳化痰的中药组合物的制备方法及应用 | |
CN103705599B (zh) | 一种治疗咳嗽的药物组合物及其制备方法 | |
CN107669784A (zh) | 一种防治与治疗鼻敏感及鼻窦炎的中药使用方法及生产工艺 | |
CN107137458A (zh) | 一种治疗口腔疾病的维吾尔药组合物破壁制剂及生产方法 | |
CN106110104A (zh) | 一种治疗支气管炎的中药组合物 | |
CN105477245A (zh) | 一种治感冒药包 | |
CN101259211A (zh) | 一种治疗急、慢性咽炎的药物组合及其制备方法 | |
CN104840795A (zh) | 一种治疗小儿干咳的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ZHUHAI BAODE RUNSHENG HEALTH TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BEIJING INCREASE PHARMACEUTICAL TECHNOLOGY CO., LTD. Effective date: 20150320 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100088 XICHENG, BEIJING TO: 519040 ZHUHAI, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150320 Address after: 519040 Guangdong city of Zhuhai province Jinwan District Sanzao Town Airport Road No. 288 building four floor F area B Patentee after: Zhuhai Bao Derun Health Technology Co., Ltd. Address before: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3003 Patentee before: Beijing Increase Pharmaceutical Technology Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20161223 Address after: 100088 Beijing city Xicheng District, New Street No. 2 Tiancheng Technology building block B room 3005 (Desheng Park) Patentee after: Beijing Baode Runsheng Pharmaceutical Medical Technology Development Co., Ltd. Address before: 519040 Guangdong city of Zhuhai province Jinwan District Sanzao Town Airport Road No. 288 building four floor F area B Patentee before: Zhuhai Bao Derun Health Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CB03 | Change of inventor or designer information |
Inventor after: Gao Li Inventor after: Zhang Weihua Inventor before: Gao Li |
|
CB03 | Change of inventor or designer information | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120530 Termination date: 20180123 |
|
CF01 | Termination of patent right due to non-payment of annual fee |